Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

INNOVATE (VATE) EBITDA: 2009-2025

Historic EBITDA for INNOVATE (VATE) over the last 17 years, with Sep 2025 value amounting to $11.8 million.

  • INNOVATE's EBITDA fell 1.67% to $11.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.0 million, marking a year-over-year decrease of 47.98%. This contributed to the annual value of $65.0 million for FY2024, which is 26.46% up from last year.
  • According to the latest figures from Q3 2025, INNOVATE's EBITDA is $11.8 million, which was up 13.46% from $10.4 million recorded in Q2 2025.
  • INNOVATE's EBITDA's 5-year high stood at $35.2 million during Q2 2024, with a 5-year trough of -$6.2 million in Q1 2021.
  • Its 3-year average for EBITDA is $13.5 million, with a median of $11.8 million in 2025.
  • Per our database at Business Quant, INNOVATE's EBITDA surged by 345.83% in 2022 and then tumbled by 70.45% in 2025.
  • INNOVATE's EBITDA (Quarterly) stood at $14.2 million in 2021, then declined by 9.86% to $12.8 million in 2022, then spiked by 59.38% to $20.4 million in 2023, then plummeted by 58.33% to $8.5 million in 2024, then fell by 1.67% to $11.8 million in 2025.
  • Its EBITDA stands at $11.8 million for Q3 2025, versus $10.4 million for Q2 2025 and $9.3 million for Q1 2025.